3 blue chip bargains you can’t afford to miss!

Royston Wild looks at three FTSE 100 (INDEXFTSE: UKX) stars dealing far too cheaply at current prices.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

FTSE 100 (INDEXFTSE: UKX) cut-price flyer easyJet (LSE: EZJ) continues to toil as investors digest the possible impact of Brexit on future revenues.

Brokers have taken the red pen to their earnings forecasts in recent weeks, prompted by profit warnings in the wake of the referendum. Consequently easyJet is now expected to endure a 22% bottom-line slide in the year to September 2016, breaking the firm’s long-running record of meaty earnings growth.

However, this leaves the Luton business dealing on a meagre P/E rating of 9.6 times, suggesting that the risks facing easyJet are more than priced-in at present.

While tough economic conditions in the UK have muddied the waters, I reckon surging traffic elsewhere — aided by easyJet’s steady route expansion programme on the continent — should underpin excellent long-term sales expansion. Indeed, the company moved 7.6m passengers in July, up 6.7% year-on-year.

And a brilliant 5.1% dividend yield, smashing the blue chip average of 3.5%, underlines easyJet’s position as a great value contrarian pick, in my opinion.

Parcels powerhouse

Packages giant Royal Mail (LSE: RMG) is also suffering following June’s EU referendum as the prospect of a lengthy recession — and with it significant pressure on consumer spending habits — hangs in the air.

This would of course have a huge impact on parcel volumes at Royal Mail, the company benefitting in recent times from the breakneck growth of online shopping.

I believe there’s still plenty of reason to be optimistic, however. Indeed, the likelihood of significant discounting by retailers should stop parcel activity falling off a cliff. Meanwhile, Royal Mail’s GLS European division should take some of the sting out of any immediate problems in its core markets.

A P/E rating of 12.3 times for the year to March 2017, created by an anticipated 1% earnings uptick, certainly suggests good value in my opinion. And a dividend yield of 4.5% puts the icing on the cake.

The right medicine

On paper, GlaxoSmithKline (LSE: GSK) doesn’t fall within the usual parameters associated with top value stocks.

For 2016 the drugs developer is expected to bask in a 27% earnings surge. But this results in a P/E multiple of 17.4 times, falling outside the FTSE 100 average of 15 times.

I reckon GlaxoSmithKline is still great value at this price however, particularly as 2016 is likely to prove a watershed in the firm’s growth story. The company has seen earnings collapse in each of the past four years as patent expirations in sales-driving labels have weighed.

But huge investment in fast-growing therapy areas like vaccines, helped by shrewd acquisitions and joint ventures in recent years, has transformed GlaxoSmithKline’s revenues outlook for the coming years. And I expect accelerating healthcare spending in emerging markets to drive earnings still higher.

Meanwhile, a planned 80p per share dividend — yielding a handsome 4.8% — offsets GlaxoSmithKline’s slightly-toppy earnings ratio.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

3 of my top FTSE 250 stocks to consider buying before April

Buying undervalued UK shares can be a great way to generate long-term wealth. Here, Royston Wild reveals a handful on…

Read more »

Ice cube tray filled with ice cubes and three loose ice cubes against dark wood.
Investing Articles

Just released: our 3 top income-focused stocks to buy before April [PREMIUM PICKS]

Our goal here is to highlight some of our past recommendations that we think are of particular interest today, due…

Read more »

Investing Articles

Is this the best chance to buy cheap FTSE 100 shares in a generation?

I want to buy shares when they're cheap, and sell... never, just keep taking the dividends. And the FTSE 100…

Read more »

Man putting his card into an ATM machine while his son sits in a stroller beside him.
Investing Articles

Could NatWest shares be 2024’s number one buy for passive income?

For those of us looking to earn some long-term passive income, how does NatWest's 7% dividend yield sound? It sounds…

Read more »

Investing Articles

£12K in savings? Here’s how I could turn that into £13K annual passive income

This Fool explains how investing a lump sum can help her build a passive income stream to enjoy in her…

Read more »

Aerial shot showing an aircraft shadow flying over an idyllic beach
Investing Articles

Here’s why Rolls-Royce shares are now set to fly over the £4 mark

Once again, Rolls-Royce shares are crushing the FTSE 100. Should I add to my holding of this stock at the…

Read more »

Investing Articles

1 under the radar FTSE 100 AI stock investors should consider buying

Our writer explains why this FTSE 100 pick could be a shrewd investment with its established experience of using AI…

Read more »

Investing Articles

Does the beaten-down Diageo share price make it a no-brainer buy?

Harvey Jones spent years waiting for the Diageo share price to look like good value, before finally buying it in…

Read more »